73 filings
Page 3 of 4
DEFA14A
eawcq6bp55n76
29 Apr 22
Additional proxy soliciting materials
4:47pm
DEF 14A
u0se yrv5d
29 Apr 22
Definitive proxy
4:45pm
8-K
5oaxsnke sppp
29 Apr 22
Entry into a Material Definitive Agreement
8:00am
S-8
7b6 u6ezxiwhmzdacrus
30 Mar 22
Registration of securities for employees
4:56pm
10-K
bk53tcy oz6
30 Mar 22
Annual report
4:51pm
8-K
ocps8ltga73k1gx
30 Mar 22
Aerovate Therapeutics Announces Full-Year 2021 Financial Results
4:45pm
8-K
m2fqhrv0mqxu0hd0gt
15 Dec 21
Aerovate Therapeutics Announces Initiation of IMPAHCT Phase 2b/Phase 3 Trial of AV-101 In Pulmonary Arterial Hypertension
8:00am
8-K
iigde 2uwb6
15 Nov 21
Aerovate Therapeutics Announces Third Quarter 2021 Financial Results
8:00am
10-Q
w5h6fnnf3ldryk3
16 Aug 21
Quarterly report
8:08am
8-K
z1bvq75 mnn9i6
16 Aug 21
Aerovate Therapeutics Announces Second Quarter 2021 Financial Results
8:05am
8-K
qzx35m g8
12 Aug 21
Entry into a Material Definitive Agreement
5:27pm
8-K
hxkf5un1
19 Jul 21
Aerovate Therapeutics Appoints Allison Dorval To Its Board of Directors
8:18am
8-K
tc7xjr um
2 Jul 21
Amendments to Articles of Incorporation or Bylaws
4:33pm
S-8
pfm4kdoezxxiwni0066o
30 Jun 21
Registration of securities for employees
5:02pm
424B4
s42byt2cy8lm3c
30 Jun 21
Prospectus supplement with pricing info
4:59pm
EFFECT
5q2n1jed
30 Jun 21
Notice of effectiveness
12:15am
S-1MEF
5ui3f
29 Jun 21
Registration of additional securities for an S-1
7:10pm
CERT
yo3xu75c gpxcfovmh49
29 Jun 21
Certification of approval for exchange listing
11:45am
8-A12B
ferclayc0pkm2kqq y6
25 Jun 21
Registration of securities on exchange
4:07pm